Caricamento...
An update on antibody-based immunotherapies for Clostridium difficile infection
Clostridium difficile continues to be one of the most prevalent hospital-acquired bacterial infections in the developed world, despite the recent introduction of a novel and effective antibiotic agent (fidaxomicin). Alternative approaches under investigation to combat the anaerobic Gram-positive bac...
Salvato in:
| Pubblicato in: | Clin Exp Gastroenterol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975149/ https://ncbi.nlm.nih.gov/pubmed/27536153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S84017 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|